| 标题 |
Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:S. Banerjee; A.M. Oza; M.J. Birrer; E.P. Hamilton; J. Hasan; et al 出版日期:2018-01-31 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)